Skip to main content
News Icon

News categories: Honors & Funding

Roger de Spoelberch Prize goes to Frank Bradke

Frank Bradke, a senior researcher at the German Center for Neurodegenerative Diseases (DZNE) and a professor at the University of Bonn, will be awarded the Roger de Spoelberch Prize, which is endowed with 750,000 euros. The Swiss Roger de Spoelberch Foundation thereby honors his studies on the growth and regeneration of neurons. Bradke’s research aims to lay the basis for novel therapies, especially for the treatment of spinal cord injuries. The award ceremony will be held in December 2019 in Geneva.

“This is a great honor and a tremendous motivation for me and my team,” says Bradke. “Our research is pursuing some interesting approaches. However, I would like to emphasize that we do fundamental science. Certainly, we hope to gain insights that will ultimately benefit patients. That’s exactly what we are doing research for. But there is still a long way to go.”


Contact

Prof. Dr. Frank Bradtke

German Center for Neurodegenerative Diseases (DZNE)

frank.bradke@dzne.de

Related news

Speakers of ImmunoSensation

News categories: Honors & Funding

ImmunoSensation goes into the next round

The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry
Kerstin Ludwig

News categories: Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry
Reckzeh News

News categories: Honors & Funding

Creating Personalized Cancer Treatments

Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry

Back to the news overview